The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
Elfun International Equity EGLBX
- NAV / 1-Day Return 27.59 / −0.54 %
- Total Assets 186.7 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.440%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Growth
- Min. Initial Investment 500
- Status Open
- TTM Yield 1.72%
- Turnover 9%
USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:20 PM GMT+0
Morningstar’s Analysis EGLBX
Will EGLBX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 30.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
AstraZeneca PLC | 3.55 | 6.5 Mil | Healthcare |
ASML Holding NV | 3.44 | 6.3 Mil | Technology |
Novartis AG Registered Shares | 3.23 | 5.9 Mil | Healthcare |
SAP SE | 3.11 | 5.7 Mil | Technology |
Schneider Electric SE | 2.93 | 5.4 Mil | Industrials |
Roche Holding AG | 2.92 | 5.3 Mil | Healthcare |
Tokio Marine Holdings Inc | 2.88 | 5.3 Mil | Financial Services |
Recruit Holdings Co Ltd | 2.77 | 5.1 Mil | Communication Services |
Mitsubishi UFJ Financial Group Inc | 2.74 | 5.0 Mil | Financial Services |
London Stock Exchange Group PLC | 2.56 | 4.7 Mil | Financial Services |